To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS).

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS) / Revicki, Dennis A; Luo, Michelle P; Wordsworth, Paul; Wong, Robert L; Chen, Naijun; Davis, John C; Atlas, ; Salvarani, Carlo. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 35:7(2008), pp. 1346-1353.

Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).

SALVARANI, CARLO
2008

Abstract

To evaluate the effect of adalimumab on pain, fatigue, and stiffness in patients with active ankylosing spondylitis (AS).
2008
sì
Inglese
35
7
1346
1353
WOS:000257554400021
2-s2.0-47349103012
18484692
Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Humans; Male; Middle Aged; Quality of Life; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha
none
info:eu-repo/semantics/article
Contributo su RIVISTA::Articolo su rivista
262
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS) / Revicki, Dennis A; Luo, Michelle P; Wordsworth, Paul; Wong, Robert L; Chen, Naijun; Davis, John C; Atlas, ; Salvarani, Carlo. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 35:7(2008), pp. 1346-1353.
Revicki, Dennis A; Luo, Michelle P; Wordsworth, Paul; Wong, Robert L; Chen, Naijun; Davis, John C; Atlas, ; Salvarani, Carlo
8
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1079842
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 69
  • ???jsp.display-item.citation.isi??? 61
social impact